The value of erythromycin pleurodesis in treatment of spontaneous pneumothorax

The research was carried out to observe the effect of erythromycin pleural fixation in treatment of spontaneous pneumothorax. The 160 patients who had been treated for spontaneous pneumothorax were selected as research objects. They were treated with erythromycin pleural fixation. Statistics were made on the intraoperative blood loss, analgesic dosage, thoracic drainage volume and postoperative hospital stay of the patients. In addition, the overall treatment efficiency of the patients was calculated, and VAS score and SF-36 scale were used to observe the pain degree and quality of life of the patients. The overall treatment efficiency was 87.50% (140/160). Intraoperative blood loss was (106.18 +/- 19.03) mL, analgesic dosage was (145.90 +/- 20.16) mg, chest drainage was (205.27 +/- 34.23) mL and postoperative hospital stay was (4.7 +/- 1.2) days. The white blood cell count, neutrophil cell count and mononuclear cell count were recorded. The results showed there were no significant differences in these three indexes before and after the treatment, p>0.05. None of the patients had serious adverse reaction problems. Hence the conclusion was drawn that erythromycin pleurodesis can be used to treat spontaneous pneumothorax patients, and achieve good results.